Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates
January 25, 2021 at 08:36 AM EST
Merck announced that the company is discontinuing the development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|